STOCK TITAN
  1. Home
  2. Sec-filings
  3. VMD
  4. [Form 4] VIEMED HEALTHCARE, INC. Insider Trading Activity

Viemed Healthcare (VMD) General Counsel details RSU and phantom unit vesting

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Viemed Healthcare’s General Counsel, Jeremy Trahan, reported equity award vesting and related share movements in company stock. On January 29, 2026, 10,774 restricted stock units converted into the same number of common shares, while 2,939 shares were withheld by the company to cover taxes at a value of $7.48 per share.

The filing also shows 3,591 cash-settled phantom share units vesting, economically equivalent to common shares and settled in cash with matching share movements. After these transactions, Trahan directly holds 46,492 common shares, plus 10,773 restricted stock units and 3,591 phantom share units as continuing equity interests.

Positive

  • None.

Negative

  • None.
Insider Trahan Jeremy
Role General Counsel
Type Security Shares Price Value
Exercise Restricted Stock Units 10,774 $0.00 --
Exercise Phantom Share Units 3,591 $0.00 --
Exercise Common Shares 10,774 $0.00 --
Tax Withholding Common Shares 2,939 $7.48 $22K
Exercise Common Shares 3,591 $0.00 --
Disposition Common Shares 3,591 $7.48 $27K
Holdings After Transaction: Restricted Stock Units — 10,773 shares (Direct); Phantom Share Units — 3,591 shares (Direct); Common Shares — 49,431 shares (Direct)
Footnotes (1)
  1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. Per share value is based on the market closing price of the common shares for January 29, 2026. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date. Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Trahan Jeremy
(Last) (First) (Middle)
625 E. KALISTE SALOOM RD.
(Street)
LAFAYETTE LA 70508
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 01/29/2026 M 10,774 A (1) 49,431 D
Common Shares 01/29/2026 F 2,939(2) D $7.48(3) 46,492 D
Common Shares 01/29/2026 M 3,591 A (4) 50,083 D
Common Shares 01/29/2026 D 3,591 D $7.48(3) 46,492 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 01/29/2026 M 10,774 (5) 01/29/2027 Common Shares 10,774 $0 10,773 D
Phantom Share Units (4) 01/29/2026 M 3,591 (6) 01/29/2027 Common Shares 3,591 $0 3,591 D
Explanation of Responses:
1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
3. Per share value is based on the market closing price of the common shares for January 29, 2026.
4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
5. Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
6. Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Remarks:
/s/ Jesse Bergeron, Attorney-in-Fact 02/02/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Viemed Healthcare (VMD) report for Jeremy Trahan?

Viemed Healthcare’s General Counsel Jeremy Trahan reported equity award vesting on January 29, 2026. 10,774 restricted stock units converted into common shares, and 3,591 phantom share units vested, with related share movements and tax withholding also reflected in the Form 4 filing.

How many Viemed Healthcare (VMD) common shares does Jeremy Trahan own after this Form 4?

After the reported transactions, Jeremy Trahan directly owns 46,492 Viemed Healthcare common shares. In addition, he holds 10,773 restricted stock units and 3,591 phantom share units, which provide further equity-linked exposure to the company’s stock over time.

What restricted stock unit activity did Viemed Healthcare (VMD) disclose for January 29, 2026?

The Form 4 shows 10,774 restricted stock units vesting into an equal number of Viemed Healthcare common shares on January 29, 2026. These RSUs were originally granted on January 29, 2024 and vest in three equal annual installments beginning on the first anniversary of the grant.

Why were 2,939 Viemed Healthcare (VMD) shares withheld in Jeremy Trahan’s Form 4?

The 2,939 shares were withheld by Viemed Healthcare to satisfy Jeremy Trahan’s tax obligations from restricted stock unit vesting. The per-share value used was $7.48, equal to the market closing price of the company’s common shares on January 29, 2026.

What are Viemed Healthcare (VMD) phantom share units reported in this filing?

The phantom share units are cash-settled awards under Viemed’s Phantom Share Unit Plan. Each unit is economically equivalent to one common share. On January 29, 2026, 3,591 phantom share units vested, triggering offsetting acquisitions and dispositions of underlying common shares for cash settlement.

When were the Viemed Healthcare (VMD) RSUs and phantom share units originally granted?

Both the restricted stock units and phantom share units were granted on January 29, 2024. Each award vests in three equal annual installments, starting on the first anniversary of the grant date, creating a multi-year equity-based compensation schedule for Jeremy Trahan.